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Abstract 
Inflammatory pseudotumors (IPT) form a group of etiologically, histologically, and 
biologically heterogeneous tumefactive lesions that are histologically characterized by 
prominent inflammatory infiltrates. IPT has been described in various organs including 
the lungs, bladder, liver, spleen, heart, and others. It may mimic a malignant tumor 
clinically and radiologically. We report a case of a 26-year-old woman with an ALK1-
negative IPT (7 cm in maximal diameter) mainly located in the 12th right back muscles, 
surrounding a fractured rib. Histologically, the tumor consisted of an inflammatory 
infiltrate composed predominantly of diffusely distributed lymphoplasmacytic cells and 
stromal fibroblasts associated with focal obliterative phlebitis. Conservative steroid 
treatment resulted in complete remission and the patient remained disease-free for 
more than 1 year later. To our knowledge this is the first report of IPT involving the 
skeletal back muscle and complete resolution under corticosteroid treatment. 
Introduction 
The term ‘inflammatory pseudotumor’ (IPT) has historically been applied to a 
heterogeneous group of mass-forming lesions characterized by a prominent inflammatory 
infiltrate as the predominant cellular component. However, several lesions previously 
considered variants of IPT have been identified as specific entities; some of them Case Rep Oncol 2011;4:304–310 
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represent true neoplasms. The neoplastic variants of IPT include inflammatory 
myofibroblastic tumor (IMT) associated with ALK-1 translocation [1] and IPT-like 
follicular dendritic cell tumor of the liver and spleen related to clonal Epstein-Barr virus 
(EBV) infection [2]. In contrast, mycobacterial spindle-cell IPT of lymph node [3] and 
tumefactive lesions associated with immunoglobulin G4 (IgG4) [4] represent examples of 
infectious and autoimmune-induced IPT, respectively. Orbital IPT was identified recently 
as a member of IgG4-related IPT [5]. The etiology and pathogenesis of IPT of lymph node 
and a variety of tumorous inflammatory lesions lacking features of the entities listed 
above (IPT, not otherwise specified) remain unclear; both reactive-infectious and 
immunological/idiopathic factors might play a role in their initiation and growth. Given 
the controversy that accompanied the natural history of IPT and the different criteria 
used by different authorities in their diagnosis, it is difficult to obtain clear evidence about 
the incidence, anatomical distribution and malignant characteristics of IPTs in the 
literature. For example IMTs, which were formerly regarded as IPTs, are now classified as 
neoplastic lesions. Coffin et al. [6] reported 59 cases of IMT of which 6 had metastasized. 
In contrast, the entities IPT of lymph nodes and spleen are referred to as benign lesions 
[3].  
We report a case of an IPT consisting of an inflammatory infiltrate composed 
predominantly of diffusely distributed plasma cells and lymphoid cells, involving the 
skeletal paravertebral muscle of the back and associated with a fractured rib with 
complete remission under corticosteroid treatment.  
Case Report 
A 26-year-old woman presented with an 8-month history of right-sided back pain of an intermediate 
severity. She also noticed a growing mass at the right back. The pain started suddenly in the morning 
with a sound ‘like a breaking bone’ without trauma. However, the patient reported a history of trauma 
half a year before the onset of symptoms, when somebody crashed into her right back on a swimming 
pool slide. After that trauma she had had only some mild pain for a couple of days. The patient also 
suffered from depression since her teens which required intermediate admissions. She was treated with 
paroxetine, a selective serotonin reuptake inhibitor, and opipramol, a tricyclic antidepressant, but took 
no other medication. The patient was married, and a housewife with two male children. She did use 
tobacco but no alcohol or drugs. Her grandfather had died of pancreatic cancer at the age of 60, and her 
uncle had died of a brain tumor at the age of 52. There was no other history of tumors in the family.  
At presentation, the patient had a normal weight of 67 kg and a height of 157 cm. Her blood pressure 
was at the lower normal level with 105/60 mm Hg and a pulse of 96 beats per minute. On physical 
examination there was a painful mass at the right back. It could not be mobilized and was extremely 
painful so that the patient had severe problems sleeping, especially on the right side. Laboratory results 
showed an increased C-reactive protein (41 mg/l) with a normal complete blood count, serum 
electrolytes and creatinine.  
With a clinical suspicion of a sarcoma, a computed tomography (CT) scan with i.v. contrast (88 ml 
of Imeron 400; Bracco, Konstanz, Germany) was performed which revealed a tumor measuring 7.3 × 7.1 
cm in the back muscles dorsal to the right kidney with partial compression of the pleural and 
retroperitoneal space (fig. 1a). 
The mass surrounded the 12th rib which was fractured (black arrow in fig. 1a). The contrast 
enhancement of the mass was inhomogeneous with suspected necrotic areas within the tumor. There 
was no evidence of lymphogenic or hematogenic metastases. After discussing the case in our 
interdisciplinary tumor conference we decided to perform a CT-guided biopsy. The obtained core 
needle biopsies measured 7 mm in length and were whitish-reddish with a soft consistency (fig. 2a). 
Histological examination revealed extensive tumefactive mixed inflammatory infiltrates composed Case Rep Oncol 2011;4:304–310 
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predominantly of diffusely distributed plasma cells and lymphoid cells in a strikingly sclerotic 
hyalinized background (fig. 2b–d). Neutrophils and eosinophils were absent in the inflammatory 
infiltrates. The stromal hyalinosis was very reminiscent of amyloid deposits in some areas, but Congo 
Red stain (with examination under polarized light) was negative for amyloid. Small scattered follicle-like 
lymphoid aggregates could also be seen. A remarkable finding was the presence of isolated venous 
vessels with obliterated lumens as a consequence of fibrointimal dysplasia and/or mononuclear 
inflammatory cells within strikingly thickened intima indicating obliterative phlebitis (fig. 2b, c). 
However, there was no evidence of fibrinoid vascular necrosis, leukocytoclasia or granuloma. 
Immunohistochemistry (CD138, CD3 and CD20) confirmed a mixed inflammatory infiltrate. The 
lymphoid cells were of T- and B-lineage with a slight predominance of T-cells. Staining for ALK-1 was 
negative. Staining for IgG4 showed only rare staining cells (<2 cells in 10 high power fields). The 
findings were then interpreted as consistent with an IPT, not otherwise specified. An FDP-PET/CT scan 
showed only a very mild FDP uptake. The rib fracture seemed to be an old one. 
The patient was initially treated with 120 mg prednisolone for 2 weeks which was tapered down to 
reach 40 mg after 1 month. The mass began to shrink and symptoms resolved. One month after the 
beginning of treatment, radiological examination revealed no residual tumor tissue, indicating complete 
response (fig. 1b). Corticosteroid treatment was then slowly reduced to reach 5 mg/d after 6 months and 
than tapered off. On periodic MRT scans up to 1 year later, there was no evidence of residual tumor or 
tumor regrowth (fig. 1c). 
Discussion 
We present a case of a 26-year-old woman with an IPT at the right back mainly 
involving the skeletal paravertebral muscle of the back surrounding a fractured 12th rib. 
The cause of IPT is unclear [3]. Association between EBV and IPT of the spleen and the 
liver has been well established [7]. Human herpesvirus-8 genes are suspected to play a role 
in pulmonary IMTs [8]. Other authors believe that autoimmunogenic processes are the 
underlying cause of IMT or IPT [9, 10]. Some authors suggested that chronic infection, 
for example caused by long-term retention of misplaced sutures [11] or a ruptured 
diverticulum [12], is the underlying cause which may lead to IPTs in some of the cases.  
In our case, no definite cause could be detected. It remains unclear if there is a 
correlation with the mild trauma experienced 6 months before. After that trauma the 
patient had had some pain for a few days followed by complete resolution of her 
symptoms for 6 months. Pain started again suddenly, which was, according to the 
patient’s history, most likely due to a pathologic fracture of the 12th rib. Consequently, we 
suspect the IPT to be the cause of the pathologic fracture. However, the reverse cannot be 
ruled out and the relationship between the fracture of the rib and the IPT remains 
speculative. Furthermore, our patient did not show any signs of a predisposition for 
autoimmune diseases and no acute or chronic infection was known. 
The pertinent differential diagnoses of this lesion include ALK-positive IMT [6], 
amyloid tumor/light chain disease, plasmacytoma, sclerosing low-grade malignant 
lymphoma, IgG4-associated systemic fibrosclerosis/pseudotumor and vasculitis. All these 
possibilities could be ruled out based on well-established conventional histological criteria 
assisted by histochemical and immunohistochemical stains. A systemic vasculitis was 
excluded by both clinical findings and the predominance of the extravascular 
inflammatory infiltrates, as well as by the absence of other more pathognomonic 
histological features of autoimmune vasculitis. In the literature, there are several reports 
in which corticosteroids where successfully used for the treatment of IPT. Most cases are 
described for IPT of the orbita for which usually 60 to 100 mg prednisone per day were Case Rep Oncol 2011;4:304–310 
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used. However, also higher doses up to 1,000 mg methylprednisolone have been 
administered [13]. An IPT of the lung in a 56-year-old male was successfully treated with 
an initial dose of 20 mg prednisolone per day and no recurrence was observed after 10 
years of follow-up [14]. In our case we used prednisolone with an initial dose of 120 mg/d 
for the first 2 weeks. Symptoms resolved remarkably fast with no evidence of residual 
tumor or tumor regrowth after 1 year.  
In summary, we reported an unusual case of an IPT that resolved completely under 
corticosteroid treatment. It is important to recognize cases like our current case in order 
to avoid unnecessary radical surgery, chemotherapy, or radiation therapy, since they 
might be successfully treated with corticosteroids. 
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Fig. 1. a Spiral CT at the level of the upper pole of the right kidney after i.v. contrast. Enhancing mass 
(white arrows) with a diameter of 7.1 × 7.3 cm surrounding the 12th fractured rib (black arrow). 
b Spiral CT 1 month after treatment. The fractured rib is marked (white arrow). c T1-weighted MR at 
the level of the upper pole of the right kidney. Macroscopically complete remission of the tumor and 
12th symmetric muscles of the back. Note unchanged fracture of the rib (white asterisk). 
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Fig. 2. a, b Tumefactive inflammatory infiltrates composed predominantly of diffusely distributed 
plasma cells and lymphoid cells in a strikingly sclerotic hyalinized background. A venous vessel with 
obliterated lumen is marked (black arrows). c Fibrointimal dysplasia was evident. d The background 
stromal cells showed amyloid-like hyaline changes but were negative for Congo red stain. Note 
prominent plasma cells. 
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